• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉栓塞术用于闭合肝细胞癌明显的动门脉分流以实现放射性栓塞:一例报告。

Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report.

作者信息

Wang Xiang-Dong, Ge Nai-Jian, Yang Ye-Fa

机构信息

Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.

出版信息

World J Gastrointest Surg. 2023 Dec 27;15(12):2926-2931. doi: 10.4240/wjgs.v15.i12.2926.

DOI:10.4240/wjgs.v15.i12.2926
PMID:38222008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10784826/
Abstract

BACKGROUND

Marked arterioportal shunt (APS) can be a contraindication for transarterial radioembolization (TARE) because of the risk of radiation-induced liver toxicity or pneumonitis. To date, the best method to close marked APS to reduce intrahepatic shunt (IHS) and hepatopulmonary shunt (HPS) before TARE has not been elucidated.

CASE SUMMARY

This case report describes a novel strategy of embolization of the portal venous outlet to reduce IHS and HPS caused by marked APS before TARE in a patient with advanced hepatocellular carcinoma (HCC). The patient had a significant intratumoral shunt from the tumor artery to the portal vein and had already been suspected based on pre-interventional magnetic resonance angiography, and digital subtraction angiography (DSA) confirmed the shunt. Selective right portal vein embolization (PVE) was performed to close the APS outlet and DSA confirmed complete closure. Technetium-99m macroaggregated albumin was administered and single photon emission computed tomography revealed a low HPS with 8.4%. Successful TARE was subsequently performed. No major procedure-related complication occurred.

CONCLUSION

Closure of APS with PVE during mapping angiography of advanced-stage HCC to enable reduction of HPS and subsequent TARE is feasible.

摘要

背景

显著的动门脉分流(APS)可能是经动脉放射性栓塞(TARE)的禁忌证,因为存在辐射诱导的肝毒性或肺炎风险。迄今为止,在TARE之前封闭显著的APS以减少肝内分流(IHS)和肝肺分流(HPS)的最佳方法尚未阐明。

病例摘要

本病例报告描述了一种新的策略,即在一名晚期肝细胞癌(HCC)患者中,在TARE之前栓塞门静脉出口以减少由显著APS引起的IHS和HPS。该患者存在从肿瘤动脉到门静脉的显著瘤内分流,在介入前磁共振血管造影时就已怀疑,数字减影血管造影(DSA)证实了分流。进行了选择性右门静脉栓塞(PVE)以封闭APS出口,DSA证实完全封闭。给予锝-99m大颗粒白蛋白,单光子发射计算机断层扫描显示HPS较低,为8.4%。随后成功进行了TARE。未发生重大的与手术相关的并发症。

结论

在晚期HCC的造影血管成像期间用PVE封闭APS以减少HPS并随后进行TARE是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/8cca049729ee/WJGS-15-2926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/ee6ba1aff742/WJGS-15-2926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/1b133c2d76e7/WJGS-15-2926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/8cca049729ee/WJGS-15-2926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/ee6ba1aff742/WJGS-15-2926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/1b133c2d76e7/WJGS-15-2926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cb/10784826/8cca049729ee/WJGS-15-2926-g003.jpg

相似文献

1
Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report.门静脉栓塞术用于闭合肝细胞癌明显的动门脉分流以实现放射性栓塞:一例报告。
World J Gastrointest Surg. 2023 Dec 27;15(12):2926-2931. doi: 10.4240/wjgs.v15.i12.2926.
2
Hepatopulmonary shunting in patients with primary and secondary liver tumors scheduled for radioembolization.计划接受放射性栓塞治疗的原发性和继发性肝肿瘤患者的肝肺分流。
Eur J Radiol. 2015 Feb;84(2):201-7. doi: 10.1016/j.ejrad.2014.11.004. Epub 2014 Nov 13.
3
Pre-transarterial Radioembolization of Tumoral Arteriovenous Fistula Associated With Recanalized Umbilical Vein Shunt in a Case of Hepatocellular Carcinoma With Hepatic Vein and Inferior Vena Cava Invasion.肝细胞癌伴肝静脉和下腔静脉侵犯患者肿瘤动静脉瘘合并再通脐静脉分流的经动脉放射性栓塞治疗
Cureus. 2023 Sep 6;15(9):e44784. doi: 10.7759/cureus.44784. eCollection 2023 Sep.
4
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.一种估算钇-90玻璃基放射性栓塞治疗后肝细胞癌所接受剂量的简单方法:概念验证研究的初步结果
J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007.
5
[Diagnostic capability of multidetector CT for arterioportal shunt in hepatocellular carcinoma].[多层螺旋CT对肝细胞癌动脉门静脉分流的诊断能力]
Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):231-3.
6
Short-Term Oral Sorafenib for Therapy of Intratumoral Shunts of Hepatocellular Carcinoma to Enable Intraarterial Treatment.短期口服索拉非尼治疗肝细胞癌肿瘤内分流以实现肝动脉治疗。
Cardiovasc Intervent Radiol. 2019 Oct;42(10):1494-1499. doi: 10.1007/s00270-019-02294-7. Epub 2019 Jul 30.
7
Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.经颈静脉肝内门体分流术联合经导管栓塞/化疗栓塞治疗门静脉高压合并动门脉分流的肝细胞癌的疗效与安全性
Abdom Radiol (NY). 2021 Nov;46(11):5417-5427. doi: 10.1007/s00261-021-03214-5. Epub 2021 Jul 24.
8
Transarterial embolization with cyanoacrylate for severe arterioportal shunt complicated by hepatocellular carcinoma.经动脉栓塞术用氰基丙烯酸酯治疗严重肝动脉门静脉分流并发性肝细胞癌。
Cardiovasc Intervent Radiol. 2013 Apr;36(2):412-21. doi: 10.1007/s00270-012-0410-4. Epub 2012 May 12.
9
Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.基于锥形束 CT 的虚拟实质灌注算法在预测 HCC 放射性栓塞治疗计划中 SPECT/CT 解剖和容积结果的准确性和可重复性。
Eur Radiol. 2023 May;33(5):3510-3520. doi: 10.1007/s00330-023-09390-w. Epub 2023 Jan 18.
10
Software development for hepatopulmonary shunt estimation by gamma camera method in transarterial radioembolization.经动脉放射性栓塞术中基于γ相机法的肝肺分流估计软件开发
World J Nucl Med. 2019 Dec 18;18(4):366-372. doi: 10.4103/wjnm.WJNM_115_18. eCollection 2019 Oct-Dec.

本文引用的文献

1
Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients.索拉非尼治疗肝细胞癌患者后肝肺和肝内分流减少。
Cardiovasc Intervent Radiol. 2022 Dec;45(12):1842-1847. doi: 10.1007/s00270-022-03283-z. Epub 2022 Sep 29.
2
SIRT in 2025.SIRT 在 2025 年。
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1622-1633. doi: 10.1007/s00270-022-03228-6. Epub 2022 Aug 8.
3
Radioembolization for Hepatocellular Carcinoma: The Effects of Arterioportal Shunts on Nontargeted Liver Hypertrophy.
肝癌的放射性栓塞治疗:肝动脉-门静脉分流对非靶向性肝肥大的影响。
J Vasc Interv Radiol. 2022 Jul;33(7):787-796.e4. doi: 10.1016/j.jvir.2022.03.023. Epub 2022 Mar 26.
4
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.肝细胞癌(HCC):流行病学、病因学和分子分类。
Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28.
5
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.肝细胞癌的局部区域治疗方法:最新进展与管理策略
Cancers (Basel). 2020 Jul 15;12(7):1914. doi: 10.3390/cancers12071914.
6
Same-Day Repeat Hepatopulmonary Shunt Measurement during Planning Angiography for Hepatic Radioembolization.肝动脉放射性栓塞计划血管造影期间的同日重复肝肺分流测量
J Vasc Interv Radiol. 2020 Jul;31(7):1069-1073. doi: 10.1016/j.jvir.2020.03.006. Epub 2020 May 18.
7
Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization.钇-90放射性栓塞治疗中高肝肺分流的管理
Tech Vasc Interv Radiol. 2019 Jun;22(2):58-62. doi: 10.1053/j.tvir.2019.02.004. Epub 2019 Feb 27.
8
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma.与肝细胞癌相关的肝动脉门静脉分流的临床特征。
BMC Gastroenterol. 2018 Nov 12;18(1):174. doi: 10.1186/s12876-018-0899-3.
9
Transarterial embolization with N-butyl 2-cyanoacrylate for the treatment of arterioportal shunts in patients with hepatocellular carcinoma.用N-丁基2-氰基丙烯酸酯进行经动脉栓塞治疗肝细胞癌患者的动门脉分流
J Cancer Res Ther. 2017;13(4):631-635. doi: 10.4103/jcrt.JCRT_286_17.
10
Balloon-Assisted Chemoembolization Using a Micro-Balloon Catheter Alongside a Microcatheter for a Hepatocellular Carcinoma with a Prominent Arterioportal Shunt: A Case Report.使用微球囊导管联合微导管对伴有明显动门脉分流的肝细胞癌进行球囊辅助化疗栓塞:一例报告
Cardiovasc Intervent Radiol. 2017 Apr;40(4):625-628. doi: 10.1007/s00270-016-1530-z. Epub 2016 Dec 16.